These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2488105)

  • 21. [Acute hemodynamic effects of intravenous administration of molsidomine in secondary pulmonary hypertension and right heart failure].
    Jahed MM
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():58-61. PubMed ID: 7968906
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrovascular effects of nitric oxide manipulation in spontaneously hypertensive rats.
    Fouyas IP; Kelly PA; Ritchie IM; Whittle IR
    Br J Pharmacol; 1997 May; 121(1):49-56. PubMed ID: 9146886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
    Slawsky MT; Colucci WS; Gottlieb SS; Greenberg BH; Haeusslein E; Hare J; Hutchins S; Leier CV; LeJemtel TH; Loh E; Nicklas J; Ogilby D; Singh BN; Smith W
    Circulation; 2000 Oct; 102(18):2222-7. PubMed ID: 11056096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic changes produced by molsidomine in patients with congestive myocardiopathy.
    Otero F; Fernández Berges DJ; Milei J; Agejas R; Vázquez A; Pautasso E
    Acta Cardiol; 1984; 39(5):353-63. PubMed ID: 6334953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary linsidomine abolishes acetylcholine-induced vasoconstriction of epicardial coronary arteries.
    Dubois-Rande JL; Dupouy P; Geschwind H; Castaigne A; Adnot S
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):462-7. PubMed ID: 7504139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
    Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of SIN-1 on peripheral hemodynamics and viscoelastic properties of aorta in anesthetized rabbits.
    Friggi A; Bodard H; Berenger FP; Esclapez F; Rolland PH
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):445-58. PubMed ID: 2487541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease].
    Münzel T; Kurz S; Heitzer T; Luhmann C; Just H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():38-41. PubMed ID: 7968900
    [No Abstract]   [Full Text] [Related]  

  • 31. Duration and reproducibility of initial hemodynamic effects of flosequinan in patients with congestive heart failure.
    Bartels GL; Remme WJ; Wiesfeld AC; Kok FJ; Look MP; Krauss XH; Kruyssen HA
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):705-12. PubMed ID: 2076381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
    J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemodynamic effects of inhaled nitric oxide in heart failure.
    Semigran MJ; Cockrill BA; Kacmarek R; Thompson BT; Zapol WM; Dec GW; Fifer MA
    J Am Coll Cardiol; 1994 Oct; 24(4):982-8. PubMed ID: 7930234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise-induced angina alleviated by intracoronary SIN-1.
    Berkenboom GM; Unger P; Jottrand M; Loiseau J; Pype F; Degre SG
    Cardiology; 1987; 74(6):427-35. PubMed ID: 3435906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine is a selective pulmonary vasodilator in cardiac surgical patients.
    Fullerton DA; Kirson LE; Jones SD; McIntyre RC
    Chest; 1996 Jan; 109(1):41-6. PubMed ID: 8549214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracavernous application of SIN-I in rabbit and man: functional and toxicological results.
    Meyer MF; Taher A; Krah H; Staubesand J; Becker AJ; Kircher M; Mayer B; Jonas U; Forssmann WG; Stief CG
    Ann Urol (Paris); 1993; 27(3):179-82. PubMed ID: 8352581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
    Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
    Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
    JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravenous molsidomine administration in heart failure. Part I: Dose-response relationship with reference to hemodynamic parameters].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():47-9. PubMed ID: 7968903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.